Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Operating activities
Net income (loss)	$ 35,120	$ (29,142)	$ (21,501)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	6,205	5,382	4,687
Operating lease right-of-use assets expense	8,614	6,270	6,234
Foreign currency remeasurement loss	4,497	866	0
Stock-based compensation	39,315	39,059	36,048
Deferred income taxes	(2,240)	498	(864)
Allowance for credit loss on notes receivable	4,037	0	0
Other	468	(67)	1,068
Change in value of earn-out and warrant liabilities	(408)	37,276	11,454
Changes in operating assets and liabilities:
Accounts receivable	(31,300)	(4,898)	(19,448)
Prepaid expenses and other current assets	(2,658)	(3,350)	(2,773)
Deferred contract costs and other assets	(11,266)	(8,482)	(7,687)
Accounts payable, accrued expenses and other current liabilities, and other liabilities	3,383	22,443	6,882
Operating lease liabilities	(8,636)	(6,397)	(6,273)
Deferred revenue	40,126	29,436	26,867
Net cash provided by operating activities	85,257	88,894	34,694
Investing activities
Maturities of investments	167	5,353	2,620
Purchases of investments	(167)	(1,819)	(3,497)
Cash paid in business combinations, net of cash acquired	(14,893)	0	0
Capitalization of internal-use software	(1,624)	(1,211)	(1,434)
Purchase of property and equipment	(3,683)	(3,044)	(2,087)
Issuance of notes receivables	0	(1,750)	(1,250)
Other investing activities	0	(130)	0
Net cash used in investing activities	(20,200)	(2,601)	(5,648)
Financing activities
Purchase of common stock	(49,750)	(33,053)	(39,036)
Proceeds from warrant exercises	168,189	17,182	0
Proceeds from stock option exercises	17,709	11,033	5,569
Repurchase of noncontrolling interest	(12,148)	0	0
Funds held on behalf of others	6,065	0	0
Funds released on behalf of others	(6,065)	0	0
Redemption of redeemable noncontrolling interest	0	(6,130)	0
Purchase of public warrants	0	(3,991)	0
Company earn-out shares settled in cash	0	(572)	0
Other financing activities	(9)	(6)	(200)
Net cash provided by (used in) financing activities	123,991	(15,537)	(33,667)
Net increase (decrease) in cash and cash equivalents	190,325	67,573	(4,026)
Cash and cash equivalents at beginning of period	290,735	223,162	227,188
Cash and cash equivalents at end of period	481,060	290,735	223,162
Effect of exchange rates on cash	1,277	(3,183)	595
Supplemental disclosures of cash flow information
Income taxes paid	6,831	6,882	6,112
Company earn-out shares issuance	0	53,871	0
Unpaid purchase consideration transferred in connection with the business combination	$ 5,499	$ 0	$ 0